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In Brief
High salt consumption is causally linked
to hypertension with unclear etiology.
Choe et al. show that chronic high salt
modifies a hypothalamic circuit, leading
to excessive release of the antidiuretic
hormone vasopressin. The resulting
peripheral vasoconstriction increases
blood pressure.
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The mechanisms by which dietary salt promotes hy-
pertension are unknown. Previous work established
that plasma [Na+] and osmolality rise in proportion
with salt intake and thus promote release of vaso-
pressin (VP) from the neurohypophysis. Although
high levels of circulating VP can increase blood pres-
sure, this effect is normally prevented by a potent
GABAergic inhibition of VP neurons by aortic barore-
ceptors. Here we show that chronic high salt intake
impairs baroreceptor inhibition of rat VP neurons
through a brain-derived neurotrophic factor (BDNF)-
dependent activation of TrkB receptors and down-
regulation of KCC2 expression, which prevents
inhibitory GABAergic signaling. We show that high
salt intake increases the spontaneous firing rate of
VP neurons in vivo and that circulating VP contributes
significantly to the elevation of arterial pressure under
these conditions. These results provide the first
demonstration that dietary salt can affect blood pres-
sure through neurotrophin-induced plasticity in a
central homeostatic circuit.
INTRODUCTION
High levels of dietary salt intake can significantly increase
plasma sodium concentration and contribute to the develop-
ment of salt-dependent hypertension (He et al., 2013; He and
Macgregor, 2012; Schmidlin et al., 2007). However, the central
mechanisms by which excess sodium can increase blood pres-
sure (BP) remain poorly defined. Previous work has shown that a
rise in plasma sodium can excite hypothalamic magnocellular
neurosecretory cells (MNCs) that release the antidiuretic and
vasoconstrictor hormone vasopressin (VP) (Bourque, 2008;
Voisin and Bourque, 2002). Although VP can enhance BP wheninfused systemically (Fujiwara et al., 2012), increases in BP nor-
mally activate arterial baroreceptors (BR) that inhibit VP MNCs
via GABAA receptors (GABAAR) (Cunningham et al., 2002; Re-
naud et al., 1988). In principle, this negative feedback regulation
of MNCs should mitigate the involvement of circulating VP in the
development of hypertension. However, a recent study has
shown that rat MNCs display a collapse in the transmembrane
chloride (Cl) gradient required for inhibitory GABAAR signaling
after chronic salt loading (Kim et al., 2011). A similar effect can
be induced by a high-salt diet in uni-nephrectomized rats treated
with deoxycorticosterone acetate (DOCA), where aweakening of
BR-mediated inhibition is also associated with a VP-dependent
increase in BP (Kim et al., 2013). These observations indicate
that plastic changes in the BR-mediated control of MNCs can
allow these cells to participate in the regulation of BP. However, it
remains unknown if high dietary salt intake can by itself mediate
a VP-dependent form of hypertension, and the signaling mecha-
nisms responsible for state-dependent changes in the BR-medi-
ated control of VP MNCs are unknown.
Recent studies have shown that a weakening of GABAAR-
mediated inhibition caused by a collapsed Cl gradient can
emerge under several pathological conditions, including chronic
pain (Coull et al., 2003), epilepsy (Huberfeld et al., 2007), stress
(Hewitt et al., 2009), and spasticity following spinal cord injury
(Boulenguez et al., 2010). In each instance experiments revealed
that the effect was caused by a downregulation of the expression
or activity of the K+/Cl co-transporter 2 (KCC2), a molecule that
maintains the low levels of intracellular [Cl] required for inhibi-
tory GABAAR signaling (Ferrini and De Koninck, 2013). The
expression of KCC2 is tightly linked to the activity of tropomy-
sin-related kinase B (TrkB) receptors, whose activation can sup-
press KCC2 transcription (Rivera et al., 2004). Although TrkB
receptors can be activated by several ligands (McNamara and
Scharfman, 2012; Yoshii and Constantine-Paton, 2010), recent
studies have shown that the potent TrkB agonist brain-derived
neurotrophic factor (BDNF) (Lu, 2003) is a common mediator of
TrkB activation and KCC2 downregulation in central neurons
(Boulenguez et al., 2010; Coull et al., 2005; Huang et al., 2013;
Molinaro et al., 2009). Moreover, BDNF is highly expressed inNeuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc. 549
Figure 1. SL Shifts EGABA in MNCs
(A) Sweeps at left show sPSPs recorded using sharp electrodes at various voltages fromMNCs in explants prepared from EU and SL rats (see Figures S1 and S2).
Plots in the middle panel show mean (± SEM) sPSP amplitude for the cells at left against baseline voltage (arrows show EREV). Bar graphs at right represent the
mean (± SEM) of all collected EGABA values from sPSP analysis in all cells tested.
(B) Sweeps at left showPSPs evoked by electrical stimulation of the DBB at various voltages inMNCs recorded fromEU andSL explants. Plots in themiddle show
mean (± SEM) evoked PSP (ePSP) amplitudes for cells at left against baseline voltage (arrows show EREV). Bar graphs at right represent the mean (± SEM) of all
EGABA values determined from ePSP analysis (n shown on bars; ***p < 0.001).VP MNCs (Aliaga et al., 2002; Arancibia et al., 2007; Castren
et al., 1995), and in vivo experiments have shown that the
dendrites of these neurons can release BDNF in response to
electrical activity induced by a systemic increase in plasma
[Na+] (Arancibia et al., 2007). In this study we therefore investi-
gated whether chronic high dietary salt intake can provoke VP-
dependent hypertension due to a BDNF-TrkB-KCC2-mediated
weakening of BR inhibition of VP MNCs.
RESULTS
SL Depolarizes EGABA and Eliminates Inhibitory Tone
To confirm that chronic high salt intake causes a collapse of Cl
gradient in MNCs (Kim et al., 2011), we first examined the
voltage dependence of GABAAR-mediated postsynaptic poten-
tials (PSPs) using sharp electrode intracellular recordings in
hypothalamic explants prepared from euhydrated (EU) rats or
animals provided with 2% NaCl as drinking solution for 7 days
(SL; salt loading). This treatment resulted in a significant in-
crease in plasma osmolality (Figure S1), as reported previously
(Kim et al., 2011). Recordings were obtained from the VP-rich
zone of the supraoptic nucleus (see Experimental Procedures),
and DNQX (20 mM) was present to block fast ionotropic
glutamatergic transmission. The average input resistances of
recorded MNCs from EU and SL rats were 167.6 ± 14.8 MU
(n = 27) and 116.6 ± 7.9 MU (n = 33), respectively (p =
0.0016). Spontaneous PSPs (sPSPs) recorded under these con-550 Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc.ditions were completely eliminated by the addition of GABAAR
blockers bicuculline (10 mM; not shown) or gabazine (1 mM; Fig-
ure S2), confirming their dependence on these receptors. As
illustrated in Figure 1A, GABAAR-mediated sPSPs recorded in
MNCs from EU preparations were consistently hyperpolarizing
at voltages near action potential (AP) threshold (i.e., rheobase
45 mV), reversing polarity at 57.2 ± 1.5 mV (n = 14, six
rats). In contrast, sPSPs recorded in MNCs from SL prepara-
tions were generally depolarizing at voltages near AP threshold
and reversed at 36.4 ± 3.9 mV; n = 10, three rats; p = 0.000012
versus EU control).
We next examined the value of EGABA determined from the
voltage dependence of PSPs evoked in MNCs by stimulation
of the nucleus of the diagonal band of Broca (DBB), a site that re-
lays the inhibitory effect of BRs onto VP MNCs in the supraoptic
nucleus (Cunningham et al., 2002; Renaud et al., 1988). Electrical
stimulation of the DBB caused prominent gabazine-sensitive
PSPs in MNCs (Figure S2) and the average value of EGABA deter-
mined from these responses was significantly more positive
in explants prepared from SL rats (35.3 ± 2.9 mV; n = 23, eight
rats) than EU rats (59.4 ± 1.6 mV; n = 13, seven rats;
p = 0.0000015; Figure 1B). Identical results were obtained using
gramicidin perforated patch recordings from identified VP neu-
rons in angled hypothalamic slices prepared from transgenic
Wistar rats expressing enhanced green fluorescent protein
(GFP) in VP MNCs (Figures 2A–2D) and by intracellular record-
ings from the VP-rich zone of the supraoptic nucleus MNCs in
Figure 2. SL Depolarizes EGABA in MNCs
from Different Rat Strains
(A) Perforated patch-clamp recordings were made
from GFP-expressing VP MNCs in acute hypo-
thalamic slices.
(B) Recordings (average of three sweeps) from
the cells in (A) show that electrical stimulation of
the DBB (arrow) evokes PSCs, which reverse at
different voltages (as indicated) in slices from EU
and SL rats.
(C) Amplitude of evoked PSC plotted against
membrane voltage for the cells in (A) and (B).
(D) Bar graphs showmean (± SEM) values of EGABA
in identified VP MNCs in EU (n = 16, nine rats) and
SL (n = 19, six rats) slices. Circles superimposed
on the bars plot values determined in all cells
tested in both conditions.
(E) Bar graphs showmean (± SEM) values of EGABA
(circles show individual values) determined by
intracellular recording of MNCs in Sprague-Daw-
ley (S-D), Long Evans (L-E), and Fischer 344 (F344)
EU rats (n = 7, four rats; 27, 13 rats; 5, three rats,
respectively) or SL rats (n = 13, two rats; 33, 11
rats; 14, three rats, respectively). *p < 0.05; ***p <
0.001; n.s. denotes difference not statistically
significant.hypothalamic explants prepared from three different strains of
rats (Long Evans, L-E; Sprague-Dawley, S-D; and Fischer 344
rats; Figure 2E).
To establish if differences in EGABA observed in MNCs from EU
and SL rats have a functional impact on GABAAR-mediated
inhibitory tone, we examined the effects of antagonizing
GABAARs on spontaneous AP firing rate measured using non-
invasive extracellular single-unit recordings. As shown in Figures
3A and 3B, bath application of 10 mMbicuculline caused a signif-
icant excitation of MNCs in EU explants (basal 1.9 ± 0.6 Hz
versus bicuculline 2.6 ± 0.7 Hz; n = 10; p = 0.0032), consistent
with the existence of a significant inhibitory tone under control
conditions. Conversely, bath-application of bicuculline signifi-
cantly inhibited the firing rate of MNCs in SL explants (basal
2.7 ± 0.7 Hz versus bicuculline 0.9 ± 0.4; n = 17; p = 0.0243;
both paired t tests). These observations indicate that the depola-
rizing shift in EGABA induced by SL is sufficient to convert theNeuron 85, 549–560inhibitory tone that prevails under normal
conditions into an excitatory tone in the
SL condition.
SL Depolarizes EGABA via
Downregulation of KCC2
The depolarizing shift in EGABA observed
in SL MNCs indicates that the intra-
cellular concentration of chloride ([Cl]i)
is increased under these conditions.
Because [Cl]i is determined by the rela-
tive activity of the Cl exporter KCC2
and the Cl importer NKCC1 (Chamma
et al., 2012), an increase in [Cl]i could
be mediated by either an increase inNKCC1 activity and/or a decrease in KCC2 activity. To clarify
the mechanism mediating the depolarizing shift in EGABA
observed in SL MNCs, we examined the functional contribution
of these transporters under EU and SL conditions in L-E rats.
Application of the NKCC1 antagonist bumetanide (10 mM)
caused a small but significant hyperpolarization of the average
value of EGABA in MNCs from EU rats (4.4 ± 1.9 mV; n = 10;
p = 0.047; Figures 4A and 4B). This observation indicates that
NKCC1-mediated Cl import plays a role in setting the EGABA
of MNCs in these rats. If an increase in NKCC1-mediated import
was responsible for the positive shift in EGABA caused by SL, we
would expect that the hyperpolarizing effect of bumetanide on
EGABA would be enhanced in this condition. However, as illus-
trated in Figures 4A and 4B, application of bumetanide only
had a small and non-significant effect on EGABA in SL MNCs
(2.3 ± 2.9 mV; n = 12; p = 0.45). Therefore the effect of SL on
EGABA is not mediated by a change in the activity of NKCC1., February 4, 2015 ª2015 Elsevier Inc. 551
Figure 3. SL Eliminates Inhibitory Tone in Rat MNCs
(A) Excerpts of single-unit activity recorded from MNCs in EU and SL rats
before (basal) and during bath applications of 10 mM bicuculline.
(B) Scatter plot displays absolute firing rates of individual MNCs with and
without bicuculline (connected by lines) under EU (n = 10, two rats) and SL (n =
17, three rats) conditions. Bar graph overlays represent mean values (± SEM;
*p < 0.05; **p < 0.01).Application of the KCC2 antagonist furosemide (100 mM) caused
a significant and reversible depolarization of EGABA in MNCs of
EU rats (+9.5 ± 0.8 mV; n = 6; p < 0.001; Figures 4C and 4D), indi-
cating that chloride extrusion contributes to the maintenance of
a negative EGABA in MNCs from EU rats. If a decrease in KCC2-
mediated Cl export was responsible for the depolarization of
EGABA in SL MNCs, we would expect that the effect of furose-
mide would be attenuated in this condition. Indeed, furosemide
had no effect on the value of EGABA in MNCs from SL rats
(+0.1 ± 0.8 mV; n = 8; p = 0.86; Figures 4C and 4D; paired t
test was applied to all bumetanide and furosemide experiments).
Taken together, these results indicate that a reduction of KCC2
activity specifically mediates the depolarizing effect of SL on
EGABA in MNCs.
To determine if the reduced KCC2 activity caused by SL is
associated with a decrease in transporter expression, we per-
formed western blot analysis on lysates of microdissected su-
praoptic nuclei obtained from EU and SL L-E rats. As shown in
Figures 4E and 4F, the average expression of KCC2 was signif-
icantly reduced in the supraoptic nucleus of SL rats compared
to EU (p = 0.002). Furthermore, immunohistochemical staining
revealed a strong expression of KCC2 along the perimeter of
VP MNCs in EU rats, and this staining was dramatically lower
in SL rats (Figure S3). In agreement with our observations on
the effect of bumetanide on EGABA, we observed a small but552 Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc.non-significant decrease in NKCC1 expression. Therefore the
depolarization of EGABA caused by SL inMNCs is due specifically
to a reduction in Cl extrusion mediated by a decrease in KCC2
expression and activity.
SL Causes Activation of TrkB Receptors in the
Supraoptic Nucleus
Previous work has shown that a decrease in the expression and
functional activity of KCC2 can be mediated by the activation of
TrkB upon phosphorylation at tyrosine residue 515 (Y515) (Riv-
era et al., 2004). We therefore examined if this mechanism was
involved in the effect of SL on EGABA inMNCs.We first performed
western blot analysis on supraoptic nucleus lysates using anti-
bodies directed against TrkB phosphorylated at Y515 TrkB
(p-TrkB) or an unrelated TrkB epitope to measure total TrkB pro-
tein (tot-TrkB). As shown in Figures 5A and 5B, the average stain-
ing intensity of the p-TrkB protein bandwas significantly higher in
lysates obtained from SL rats than EU rats, when normalized to
either a loading control (p-TrkB/GADPH; p = 0.004) or tot-TrkB
(p = 0.026; n = 7 for both). These observations indicate that SL
causes an increase in TrkB receptor activation without affecting
the total amount of TrkB expressed in the supraoptic nucleus.
To determine if TrkB activation is required to mediate the
reduction in Cl gradient induced by SL, we examined the effect
of locally scavenging endogenously released TrkB agonist mol-
ecules during the SL treatment. To this end, micro-catheters
coupled to osmotic minipumps delivering either TrkB receptor
body (TrkB-Fc) or vehicle were stereotaxically implanted unilat-
erally into the supraoptic nucleus. Delivery of TrkB-Fc using
this approach caused a significant reduction in the density of
p-TrkB-positive cells observed in the supraoptic nucleus of SL
rats compared to the contralateral side (Figure S4), confirming
that this approach reduces the extent of TrkB activation caused
by SL.
To determine if TrkB activation is required tomediate the effect
of SL on EGABA, we examined the effect of reducing TrkB activa-
tion by scavenging TrkB agonist molecules with TrkB-Fc during
the SL treatment. As shown in Figure 5C, recordings fromMNCs
in explants prepared from SL rats in which the supraoptic nu-
cleus was infused with vehicle showed an average value of
EGABA (38.8 ± 4.06 mV; n = 13) that was equivalent to that in
non-cannulated SL rats (33.9 ± 2.2 mV; n = 52; p = 0.246)
and significantly more depolarized than control (EU) rats
(57.4 ± 1.4 mV; n = 43; p < 0.001). However, the average value
of EGABA measured in MNCs recorded from SL rats receiving
TrkB-Fc into the supraoptic nucleus (SL-TrkB-Fc rats; 53.2 ±
3.0 mV; n = 21) was significantly more hyperpolarized than
vehicle-treated animals (p = 0.003) and equivalent to that
observed in EU rats (p = 0.251; all comparisons made using
one-way ANOVA followed by Student-Newman-Keuls post-
hoc test). Furthermore, as illustrated in Figure 5D, DBB stimula-
tion failed to significantly excite MNCs from SL-TrkB-Fc rats
(evoked/baseline AP frequency = 1.63 ± 0.46; n = 6; p =
0.394), whereas the same stimulation induced a robust excita-
tion of MNCs from SL controls (3.37 ± 0.78; n = 16; p < 0.001;
both Mann-Whitney rank-sum tests; Figure S5). These observa-
tions indicate that TrkB activation is required to mediate the
depolarization of EGABA induced by SL in MNCs.
Figure 4. SL Depolarizes EGABA via Downre-
gulation of KCC2
(A) A representative time plot of EGABA measured
from EU and SL MNCs before, during, and after
application of bumetanide (shaded area).
(B) Bar graphs compare mean values (± SEM) of
EGABA measured with and without bumetanide in
groups of MNCs from EU and SL rats (n shown on
bars; four and six rats, respectively).
(C and D) Same as (A) and (B) but with application
of furosemide (three rats in each group).
(E) Sample western blot showing reduced staining
for KCC2 (175 kDa), but not for NKCC1
(130 kDa) nor loading control (GAPDH; 38 kDa)
in lysates of supraoptic nucleus obtained from EU
and SL rats (see also Figure S3).
(F) Bar graphs quantify changes in KCC2 and
NKCC1 proteins (normalized to GAPDH) analyzed
by western blots (n shown on bars; *p < 0.05; n.s.
indicates difference not statistically significant).BDNF Is Required for SL-MediatedCl– Gradient Collapse
in MNCs
The activation of TrkB receptors can be mediated by ligands
including brain-derived neurotrophic factor (BDNF), neurotro-
phin 4/5 (NT 4/5), and NT 3 (Boulle et al., 2012). However, previ-
ous work has shown that BDNF transcription is increased during
physiological and pathological states under which Cl gradient
collapse is evident in neurons (Gall, 1993; Rivera et al., 2002),
and that the transcription and secretion of BDNF by VP MNCs
increases during hyperosmotic stress (Arancibia et al., 2007).
To determine if BDNF is required for SL-mediated collapse of
the Cl gradient in MNCs, we examined the effect of knocking
down the level of BDNF in vivo using a short-hairpin RNA
(shRNA) that selectively inhibits BDNF synthesis (BDNF-shRNA;
Figure S6).
Adeno-associated viruses (AAV) driving production of BDNF-
shRNA or a scrambled sequence (scr-shRNA; used as control)
were first administered by intracerebroventricular (i.c.v.) injection
in anesthetized rats, and the animals were allowed to recover for
4–6 weeks prior to tissue collection for western blot analysis. As
illustrated in Figures 6A and 6B, the average expression of BDNF
in the anterior hypothalamus of BDNF-shRNA-treated rats was
significantly lower than controls (33.5 ± 19.3% relative to con-
trols; n = four rats in each group; p = 0.044). We next examinedNeuron 85, 549–560the effects of delivering these AAVs
by direct stereotaxic injection into the
supraoptic nucleus. This procedure sig-
nificantly reduced the average staining
intensity of immunohistochemically de-
tected BDNF in the supraoptic nucleus
of rats having received BDNF-shRNA
(60.1% ± 13.7%; n = 3 rats; p = 0.037)
compared to scr-shRNA (100.0% ±
7.1%; n = four rats; Figure S7).
To determine if the TrkB-dependent
collapse of Cl gradient and inhibitory
signaling induced by SL is mediated by
BDNF, we examined the effects of DBBstimulation on MNCs in hypothalamic explants from SL rats hav-
ing normal and reduced expression of BDNF within the supraop-
tic nucleus. As found in otherwise intact SL rats, MNCs recorded
from the supraoptic nucleus of SL rats having received scr-
shRNA were commonly depolarized and excited by DBB-
mediated activation of GABAARs (Figure 6C) at voltages near
threshold. In contrast, MNCs recorded from SL rats having
received BDNF-shRNA displayed hyperpolarizing and inhibitory
responses to DBB stimulation (Figure 6C). Moreover, the value of
EGABA measured in MNCs from SL rats subjected to BDNF
knockdown (56.2 ± 5.4 mV; n = 10) was significantly more hy-
perpolarized than in scr-shRNA animals (38.3 ± 2.6 mV; n = 9;
p = 0.005; one-way ANOVA and Student-Newman-Keuls post-
hoc test; Figure 6D) and was equivalent to EU controls
(p = 0.806; Figure 6D). These results indicate that BDNF is the
endogenous TrkB agonist responsible for the collapse in Cl
gradient observed in SL rats.
Activated Microglia Are Not Required for Cl– Gradient
Collapse
Previous studies have shown that BDNF can be released either
by activated microglia (Coull et al., 2005) or by neuronal somata
and dendrites (Kolarow et al., 2007; Kuczewski et al., 2009). A
previous study has reported that microglia in the supraoptic, February 4, 2015 ª2015 Elsevier Inc. 553
Figure 5. TrkB Receptor Activation Medi-
ates EGABA Shift in SL Rats
(A) Representative western blot showing Y515-
phosphorylated TrkB (p-TrkB), total TrkB (tot-
TrkB) (both at 85 kDa), and loading control
(GAPDH; 38 kDa) in supraoptic nucleus lysates
from EU and SL rats (see also Figure S4).
(B) Bar graphs show relative staining intensities
of p-TrkB and tot-TrkB normalized to GAPDH or
tot-TrkB.
(C) Summary of EGABA measurements in MNCs
in un-instrumented EU and SL rats, together with
values from MNCs recorded from explants pre-
pared from SL rats having received vehicle or
TrkB-Fc into the ipsilateral supraoptic nucleus
during SL treatment. Scatter plots with bar overlay
display individual and mean (± SEM) values of
EGABA obtained from EU (n = 43, 22 rats), SL
(n = 52, 17 rats, all strains), Vehicle + SL (n = 13,
two rats), and TrkB-Fc + SL (n = 21, four rats). *p <
0.05; **p < 0.01; ***p < 0.001; n.s. indicates
difference not statistically significant.
(D) Panels show the effects of DBB stimulation
(arrows) on membrane voltage measured by
intracellular recording from MNCs in explants
prepared from vehicle-treated or TrkB-Fc-treated
SL rats (six sweeps each). Note the prominent
IPSP and inhibition of AP firing observed in the
TrkB-Fc-treated cell (see also Figure S5).nucleus become activated during SL (Ayoub and Salm, 2003).
Therefore we investigated the possibility that these cells might
provide the BDNF underlying the SL-mediated Cl gradient
collapse. We first examined the morphology of microglia in the
supraoptic nucleus using immunohistochemical detection of
the microglial marker ionized calcium-binding adaptor molecule
1 (Iba1). In agreement with previous work, we found that micro-
glia in the supraoptic nucleus of EU rats resemble those in resting
states and that SL treatment leads to an activation of these cells
displayed as a significant hypertrophy of their somata and pro-
cesses (Figure 7A). Indeed, images of the supraoptic nucleus
from SL rats showed a significantly greater Iba1-positive surface
area than those fromEU rats (p = 0.002with t test; n = 12 sections
from three rats in each group; Figure 7B).
In order to examine whether the activation of microglia is
linked with the SL-induced Cl gradient collapse, we tested
the effect of inhibiting microglial activation on the EGABA of
MNCs in the supraoptic nucleus. While undergoing the SL treat-
ment, one group of rats concurrently received daily intraperito-
neal (i.p.) injections of minocycline hydrochloride (50 mg/kg), a
compound that crosses the blood-brain barrier and reduces
microglial activation in the brain (Fan et al., 2007). Another group
of rats undergoing identical SL treatment received injections of
equal amounts of saline as controls. As illustrated in Figure 7C,
the mean value of EGABA measured in MNCs from minocycline-
treated SL rats (37.3 ± 4.3 mV; n = 9) remained significantly
more depolarized than EU rats (p < 0.001) and was equivalent
to saline-injected SL rats (30.4 ± 5.0 mV; n = 7; p = 0.560) or
uninjected SL controls (p = 0.476; all one-way ANOVA followed
by Student-Newman-Keuls post-hoc test). These results indi-
cate that microglial activation is not required for SL-mediated
collapse of the Cl gradient in MNCs.554 Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc.SL Impairs BR-Mediated Inhibition of MNCs
To extend the functional significance of the findings reported
above, we next determined if the loss of GABAAR-mediated inhi-
bition caused by SL observed during in vitro recordings was suf-
ficient to impair the BR-mediated inhibition of VP MNCs in vivo.
Since it is well established that intravenous (i.v.) injection of
a-adrenoreceptor agonists such as phenylephrine (PE) inhibits
firing in VP MNCs via BR activation (Cunningham et al., 2004;
Renaud and Bourque, 1991; Renaud et al., 1988), we examined
whether this response is diminished in SL rats. In single-unit
extracellular recordings from VP MNCs in urethane-anaesthe-
tized rats, i.v. infusion of PE (2.5 mg/kg) raised the mean arterial
pressure by an equivalent amount in EU (+49.8 ± 5.3 mmHg,
n = 14) and SL animals (+53.9 ± 5.9 mmHg, n = 16; p = 0.61).
However, the significant inhibition of firing observed in neurons
recorded in EU rats (40.0 ± 10.1%; n = 10; p = 0.004; Wilcoxon
signed-rank test) was eliminated in SL rats (4.5 ± 26.6%; n =
17; p = 0.0784; paired t test; Figures 8A and 8B). Moreover, un-
like in EU rats where VPMNCswere either inhibited (9/10 cells) or
unaffected (1/10 cells), a significant proportion of VPMNCs in SL
rats were excited by BR activation (6/17 cells; p = 0.033; c2 test).
Peripheral VP Receptors Contribute to Elevated BP in
SL Rats
The results described above indicate that BR inhibition is abol-
ished in VP MNCs after SL. To determine if SL also causes an in-
crease in the basal electrical activity of VP MNCs in vivo, we
compared the spontaneous AP firing rate of these cells in EU
and SL rats. Average firing rate of VPMNCs in SL rats was signif-
icantly higher (9.4 ± 1.2 Hz, n = 23) than that in EU rats (5.5 ±
0.8 Hz, n = 13; p < 0.05; data not shown), consistent with the
increased VP secretion observed after SL (Ludwig et al., 1996).
Figure 6. AAV-Mediated Knockdown of
BDNF Prevents SL-Induced EGABA Shift
(A) Representative western blot shows that
in vivo delivery of BDNF-shRNA via i.c.v.
injection of recombinant AAV reduces the
expression of mature BDNF (mBDNF,14 kDa)
in the anterior hypothalamus compared to
the scrambled (Scr)-shRNA control. GAPDH
(38 kDa) was used as loading control (see also
Figure S6).
(B) BDNF immunostaining in the supraoptic nu-
cleus of SL rats that received stereotaxic infusions
of AAVs carrying either BDNF-shRNA (n = 3) or
Scr-shRNA (n = 4; see Figure S7). Bars represent
mean (± SEM).
(C) Superimposed traces show the effect of DBB
stimulation (arrows) on membrane voltage re-
corded by perforated patch recordings in hypo-
thalamic slices prepared from SL rats having
received Scr-shRNA or BDNF-shRNA in the
ipsilateral supraoptic nucleus during the SL
treatment. Sweeps show the effects of DBB
stimulation with baseline voltage set near rheo-
base (45 mV; upper; 20 sweeps each) or
at 55 mV (i.e., below AP threshold; six sweeps
each). Note the prominent IPSP and inhibition
of AP firing observed in the BDNF-shRNA-treated
cell.
(D) Summary of EGABA measurements in MNCs
in un-instrumented EU and SL rats, together
with values from MNCs recorded from
slices prepared from SL rats having received
scr-shRNA or BDNF-shRNA into the ipsilateral
supraoptic nucleus during SL treatment. Scatter
plots with bar overlay display individual and
mean (± SEM) values of EGABA obtained from
EU (n = 43, 22 rats), SL (n = 52, 17 rats),
Scr-shRNA+SL (n = 9, four rats), and BDNF-
shRNA+SL rats (n = 10, 6 rats). *p < 0.05;
**p < 0.01; ***p < 0.001; n.s., not statistically
significant.To determine if an increase in firing and secretion by VP MNCs
plays a role in the regulation of BP during SL, mean arterial pres-
sure (MAP) was monitored by radio telemetry in freely moving
rats. As illustrated in Figure 8C, MAP rose steadily during the
course of the 7 day SL treatment (basal BP: 97.7 ± 1.9 mmHg;
day 7: 113.5 ± 2.1 mmHg; n = 10; p < 0.001), whereas MAP re-
mained stable in EU rats over the same time period (basal BP:
98.3 ± 2.5 mmHg; day 7: 100.6 ± 2.2 mmHg; n = 6; p = 0.473;
one-way repeated-measures ANOVA with Student-Newman-
Keuls post-hoc test). To determine if peripheral VP receptors
contribute to the increase in BP induced by SL, we examined
the effect of SL on MAP in rats receiving a continuous systemic
infusion of dGly[Phaa1,d-tyr(et), Lys, Arg]VP, a VP receptor type
1 (V1R) antagonist. As shown in Figure 8C, the SL-mediated
increase in MAP was significantly lower in rats treated with the
V1R antagonist (D day 7; +8.8 ± 2.5 mmHg; n = 6) when
compared to SL controls (+15.1 ± 1.0 mmHg; n = 10; p = 0.03).DISCUSSION
GABA Hyperpolarizes and Inhibits MNCs in EU Rats
Previous extracellular recordings in vivo have shown that local
application of GABA inhibits the electrical activity of MNCs in
the rat supraoptic nucleus (Arnauld et al., 1983) and that inhibi-
tion of VP MNCs due to BR activation requires local GABAARs
(Jhamandas and Renaud, 1986). In agreement with these obser-
vations, a previous study reported that the value of EGABA
measured by perforated patch recording in VP MNCs in vitro
lies below the threshold for action potential discharge (Kim
et al., 2013). However, this result is contradicted by another
study reporting that EGABA is depolarized in VP MNCs and that
GABA excites these neurons in hypothalamic slices under con-
trol conditions (Haam et al., 2012). Because this is a critical issue
for our understanding of the network basis for regulation of
MNCs, we re-examined this issue using a variety of approaches.Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc. 555
Figure 7. SL-Induced Microglial Activation Does Not Mediate SL
Effect on EGABA
(A) Confocal images show SL-induced activation of microglia in the supraoptic
nucleus, visualized by Iba1 immunohistochemistry (scale bar = 20 mm).
(B) Bar graphs show the mean (± SEM) percentage of Iba1 immunopositive
surface area in images of supraoptic nucleus from SL rats (n = 12, three rats)
and EU rats (n = 12, three rats).
(C) Scatter plots with bar overlay display individual andmean (± SEM) values of
EGABA obtained from EU (n = 43, 22 rats) and SL rats (n = 52, 17 rats), together
with those from SL rats having received i.p. injections of vehicle (n = 7, three
rats) or minocycline (Mino; n = 9, four rats). **p < 0.01; ***p < 0.001; n.s., not
statistically significant.
Figure 8. Chronic SL Impairs BR Inhibition of VP MNCs and
Increases BP
(A) Extracellular single-unit recordings of AP firing rate in VP MNCs (lower) and
arterial pressure (upper) fromEUandSL rats in vivo. PEwas injected (i.v.) at the
arrows to increase arterial pressure.
(B) Bar graphs plot mean (± SEM) percent changes in firing rate (relative to
baseline) induced by PE in groups of MNCs from EU and SL rats (**p < 0.01;
n.s., not statistically significant).
(C) Measurements of changes in mean arterial pressure (DMAP) observed
during the course of SL (starting day 1) using radio telemetry, in EU rats (n = 6
rats), or SL rats receiving continuous i.p. infusions of either vehicle (n = 10 rats)
or V1R antagonist (n = 6 rats; *p < 0.05; n.s., not statistically significant).As shown in Figure 2, gramicidin-based perforated patch
recordings from identified VP MNCs in the supraoptic nucleus
of hypothalamic slices showed that EGABA is consistently and
significantly more hyperpolarized than rheobase (45 mV) in
EU rats. Identical results were obtained during intracellular re-
cordings from the VP-rich (ventral-caudal) zone of the supraoptic
nucleus in hypothalamic explants prepared from three different
strains of rats (Figure 2E). Our findings are therefore in agreement
with previous studies indicating that MNCs in EU rats maintain a
hyperpolarized EGABA that allows these cells to be potently in-
hibited by GABAergic synaptic inputs, including those activated
by BR activation. Although we have no explanation for the
discordant results reported by Haam and colleagues, the pre-
sent work and studies by others have shown that the neuronal
Cl gradient is a labile parameter that can be rapidly collapsed
as a result of stress (Hewitt et al., 2009) or experimental proce-
dures (Dzhala et al., 2012).
Reduced KCC2 Expression Depolarizes EGABA during SL
A previous study has reported that the depolarizing shift in EGABA
observed in MNCs from SL S-D rats is caused by an increase in
the activity and expression of theCl importer NKCC1 (Kim et al.,556 Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc.2011). Although our experiments and those of Kim and col-
leagues revealed an equivalent SL-induced shift in EGABA,
our electrophysiological analysis with blockers of KCC2 and
NKCC1 indicated that this effect is due to a SL-mediated reduc-
tion in KCC2 activity, rather than an increase in NKCC1 activity.
Our findings were corroborated by western blot analysis
showing that KCC2 expression is significantly reduced by SL in
L-E rats, whereas NKCC1 levels are not significantly increased
(Figure 4E). The absence of increased NKCC1-mediated Cl
import in SL rats may seem surprising since [Cl]i levels are
increased in this condition. However it remains possible that a
small residual NKCC1-mediated import could be sufficient to
raise [Cl]i under conditions where KCC2 activity is depressed.
Alternately, the increased value of [Cl]i that prevails in MNCs
from SL rats could simply result from the cumulative effect of
Cl influx mediated by basal synaptic and extrasynaptic
GABAAR activity and weakened Cl
 extrusion due to downregu-
lated KCC2. The basis for differences between our results and
those of Kim (Kim et al., 2011) are unknown, but two possible ex-
planations should be considered.
First, previous work has shown that the pattern of gene
expression is different in the supraoptic nucleus of different rat
strains (Hindmarch et al., 2007). Although SL has been found
to cause a depolarization of EGABA in all strains examined so far
(Fischer 344, L-E, S-D, and Wistar), it is possible that Cl trans-
port is mediated more strongly by NKCC1 in S-D rats and more
strongly by KCC2 in L-E rats. Second, the tissue preparation
methods used in the two studies were slightly different. Notably,
whereas our samples were collected by rapid microdissection of
the supraoptic nucleus immediately following removal of the
brain, samples obtained by Kim and colleagues were collected
by excision of the supraoptic nucleus from hypothalamic slices.
Given the labile nature of KCC2 expression in slices (Dzhala
et al., 2012), it is possible that this procedure can mask the
true contribution of KCC2 to Cl homeostasis in the supraoptic
nucleus. Given the ubiquitous involvement of changes in KCC2
expression as a mediator of altered [Cl]i in various pathophysi-
ological states, and the lesser degree of trauma applied to the
tissue used in our western blot and electrophysiological analysis
(i.e., acute explants), we believe that KCC2 serves as the pre-
dominant regulator of [Cl]i in the supraoptic nucleus and that
its modulation is a key contributor to the depolarizing shift in
EGABA induced by SL in vivo.
BDNF-Activated TrkB Depolarizes EGABA during SL
Our results show that SL causes the functional activation of TrkB
receptors in MNCs of the supraoptic nucleus and that activation
of these receptors is required to mediate the depolarization of
EGABA in response to this stimulus. Previous studies have shown
that KCC2 activity can be regulated by several types of TrkB-
dependent mechanisms. For example, TrkB activation has
been shown to suppress KCC2 transcription through a cAMP
response element-binding protein (CREB)-dependent pathway
(Rivera et al., 2004). Our observation that KCC2 protein expres-
sion is significantly reduced in SL rats is consistent with this
mechanism and suggests that a decrease in KCC2 synthesis
may contribute significantly to the decrease in KCC2 activity
associated with this condition. However, the involvement of
post-translational mechanisms cannot be excluded. For
example, TrkB activation has been shown to activate calpain
(Zadran et al., 2010), which can reduce KCC2 activity by proteo-
lytic cleavage (Puskarjov et al., 2012). Moreover, TrkB activation
can increase NMDA receptor activity by phosphorylation (Car-
ren˜o et al., 2011), and Ca2+ influx through NMDA receptors has
been shown to reduce KCC2 activity via endocytosis (Lee
et al., 2011). The specific mechanism(s) by which TrkB activation
downregulates KCC2 in SL MNCs remain to be determined.
Our shRNA-mediated knockdown experiments revealed that
BDNF is the agonist responsible for the activation of TrkB in
response to SL in MNCs. BDNF has also been identified as a
mediator of altered neuronal Cl homeostasis in neuropathic
pain (Coull et al., 2005) and morphine hyperalgesia (Ferrini
et al., 2013). In the latter models, experiments revealed that acti-
vated microglia secrete the BDNF required for TrkB activation
and downregulation of KCC2 (Ferrini and De Koninck, 2013).
Although SL causes microglial activation in the rat supraoptic
nucleus (Figure 7) (Ayoub and Salm, 2003), the effect of SL on
EGABA in MNCswas not prevented by inhibiting microglial activa-
tion in vivo. Therefore, an alternate possibility is that BDNF is
released by the MNCs themselves. Indeed, BDNF is known to
be released by many types of neurons in an activity-dependentmanner (Kuczewski et al., 2009), and previous work has shown
that BDNF is synthesized by MNCs (Carren˜o et al., 2011). More-
over, acute hyperosmotic conditions, which excite MNCs (Bour-
que, 2008), have been shown to enhance the transcription of
BDNF by MNC somata and to stimulate BDNF release by the
dendrites of these neurons in the supraoptic nucleus in vivo
(Aliaga et al., 2002; Arancibia et al., 2007). Therefore SL is likely
to trigger the activation of TrkB receptors as an autocrine or
paracrine response to BDNF release by the MNCs themselves.
High Salt Intake Promotes a VP-Dependent
Increase in BP
Increases in plasma sodium associated with a high level of die-
tary salt intake are linked to elevated BP in salt-sensitive hyper-
tensive patients (He et al., 2013; He and Macgregor, 2012;
Schmidlin et al., 2007), but themechanisms underlying this effect
are unclear. Hyperosmolality is a necessary consequence of hy-
pernatremia and thus activates central osmoreceptors (Bour-
que, 2008). Moreover, the recruitment of central osmoreceptor
pathways has been shown to enhance sympathetic tone through
an excitation of preautonomic neurons (Toney and Stocker,
2010) and VP release through glutamatergic excitation of
MNCs (Trudel and Bourque, 2010). Although both factors could
potentially contribute to increases in BP, the activation of BR
should normally counteract increases in BP by opposing both
mechanisms. However, our in vitro and in vivo results strongly
indicate that collapse of the Cl gradient eliminates BR inhibition
of VP-MNCs during SL, suggesting that this negative feedback
mechanism is impaired under these conditions. Moreover, in a
significant proportion of MNCs, the depolarizing response to
GABAAR activation appeared to be sufficient to produce an
excitatory response to BR activation. By promoting a further
excitation of MNCs, this functional switch in the polarity of BR
input would eventually result in enhanced VP secretion and
thus amplify the contribution of this hormone to the elevation in
BP as SL progresses. Indeed, data shown in Figure 8C indicate
that circulating VP mediates a significant proportion of the SL-
mediated increase in BP and that V1R-mediated contribution
to BP increased as a function of time during the SL protocol.
There are three known mechanisms through which circulating
VP can modulate BP. First, increases in systemic VP have been
shown to enhance BR reflex-mediated decreases in sympathetic
output though a V1R-dependent action in the area postrema
(Hasser et al., 1997). Second, VP has been shown to activate
V1R expressed at the subfornical organ to reduce BP, possibly
via a reduction of sympathetic output (Smith and Ferguson,
1997). However, in both cases V1R activation promotes a
lowering of BP. It is therefore unlikely that these mechanisms
contribute to the elevated BP found under SL. Third, V1Rs are
widely expressed in vascular smooth muscle where they
mediate a potent vasoconstrictor effect (Henderson and Byron,
2007). Moreover, VP levels reportedly associated with SL (Lud-
wig et al., 1996) appear to be sufficient to induce vasoconstric-
tion (Henderson and Byron, 2007), suggesting that increases in
circulating VP associated with SL could contribute to the eleva-
tion of BP observed under such conditions. This hypothesis is
directly supported by our finding that antagonism of V1R partially
reversed the SL-mediated elevations in BP. While the nature ofNeuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc. 557
the residual component in SL-induced BP increase after V1
blockade remains undetermined, we suspect a possible role of
hyperosmolality-induced increase in sympathetic outflow (Toney
and Stocker, 2010).
Concluding Remarks
Our results show that high salt intake can cause a collapse of the
Cl gradient across VP neurons and abolish BR-mediated nega-
tive feedback inhibition of these cells due to the activity-depen-
dent release of BDNF and downregulation of KCC2 that results
from the autocrine activation of TrkB receptors. The elevated
firing rate of MNCs associated with this condition leads to an in-
crease in VP secretion and a significant V1R-dependent increase
in BP. These findings show that state-dependent changes in
neurotrophin signaling can mediate pathological consequences
by promoting plastic changes in hypothalamic homeostatic
networks.
EXPERIMENTAL PROCEDURES
Drugs and Antibodies
Kynurenic acid was purchased from Sigma. DNQX (Tocris) was kept at a stock
concentration of 20 mM in dimethyl sulfoxide (DMSO) (Sigma). Bicuculline
methochloride, furosemide, bumetanide, and gabazine were obtained from
Tocris. V1R antagonist dGly[Phaa1,d-tyr(et), Lys, Arg]VP was purchased
from Bachem. TrkB-Fc chimera was purchased from R&D Systems.
Antibodies from commercial sources: KCC2 (1:500), pan-TrkB (1:1,000), and
GAPDH (1:5,000) from Millipore; BDNF (Santa Cruz Biotechnology; 1:100 for
WB, 1:300 for IHC); Y515 phosphorylated TrkB from Abcam (1:100); and
Iba1 fromWako chemicals (1:1,000). NKCC1 antibody (1:500) was generously
provided by Dr. R. James Turner (NIH). VP-neurophysin antibody (mouse
monoclonal, 1:100) was kindly provided by Dr. Hal Gainer (NIH).
Animals
Adult male rats were maintained on a 12:12 hr light cycle and provided with ad
libitum access to food and water except where indicated in specific protocols.
All procedures involving animals were conducted according to protocols
approved by the Facility Animal Care Committee of McGill University, Univer-
sity of Otago Animal Ethics Committee, and the Institutional Animal Care and
Use Committee of the UNT Health Science Center.
In Vitro Electrophysiological Recordings
Acute rat hypothalamic explants prepared as previously (Ghamari-Langroudi
and Bourque, 2001) were superfused (1–1.5 ml/min) with warm (31C–
33C) oxygenated (95% O2; 5% CO2, pH 7.35) artificial cerebrospinal fluid
(ACSF) comprising NaCl (104 mM), NaHCO3 (26 mM), NaH2PO4 (1.23 mM),
KCl (3mM),MgCl2 (1mM), CaCl2 (2mM), and D-glucose (10mM), andmannitol
was added to the desired osmolality. For extracellular recordings, KCl was
increased to 4 mM and CaCl was reduced to 1 mM. Recordings were made
using micropipettes (extracellular, 15–20 MU; intracellular, 80–110 MU) filled
with 2 M K-acetate.
Acute hypothalamic slices 400 mm thick were cut at an angle of 38 relative
to the surface of the cortex as described previously (Trudel and Bourque, 2010)
and submerged in warm oxygenated ACSF (same as above). Gramicidin
(Sigma) was dissolved in DMSO at a stock concentration of 0.05 mg/ml and
diluted 1:500 into K-gluconate-based internal pipette solution. Borosilicate
glass patch pipettes (3–6 MU) were pulled and filled with the gramicidin-con-
taining internal solution. Recordings from identified VP neurons were made by
targeting eGFP-expressing neurons in slices prepared from transgenic VP-
eGFP Wistar rats. After establishing gigaohm seals with target cells, EGABA
measurements were made after the pipette resistance dropped to values
between 40 and 80 MU. For both preparations, electrical stimulation was per-
formed using a DS2 Digitimer coupled to a concentric bipolar electrode (FHC,
Inc.) placed within the DBB.558 Neuron 85, 549–560, February 4, 2015 ª2015 Elsevier Inc.In Vivo Electrophysiological Recordings
The pituitary stalk and right SON of urethane-anaesthetized rats (1.25 g/kg,
Sigma) were exposed by a ventral approach through the oral cavity. Extracel-
lular single-unit recordings were made using micropipettes (15–40 MU) filled
with 0.9% saline. MNCs were identified by antidromic spikes elicited from pi-
tuitary stalk stimulation with a bipolar electrode (Science Products GmBH).
VP-MNCs were characterized by their spontaneous phasic activity or by a
lack of excitation following intravenous (i.v.) cholecystokinin (CCK) injection
(20 mg/kg, 0.5 ml/kg in 0.9% saline), or as oxytocin-MNCs by transient excita-
tion following CCK injection (Sabatier et al., 2004). At the end of the experi-
ments, the rats were killed by anesthetic overdose (60 mg/kg pentobarbitone
or 1 g/kg urethane, i.v.).
SON Tissue Lysate Preparation
Brains of age-matched EU and 7 day SL rats were rapidly removed and sub-
merged into oxygenated isosmotic ACSF, and then SON tissue blocks (1 mm3)
or the entire anterior hypothalami were excised using a pair of angled spring
scissors. Tissue lysates were then prepared by trituration in HEPES-based
buffer followed by centrifugation. Western blotting experiments were per-
formed using standard procedures and intensities of bands were quantified
using ImageJ (NIH).
Immunohistochemistry
Brains of age-matched EU and 7 day SL Long Evans rats perfused with 4%
paraformaldehyde (Sigma) were sectioned in the coronal plane (50 mm thick)
using a vibratome and stained immunohistochemically using various primary
antibodies listed above. Once prepared into slides, images of immunostained
structures were captured as continuous stacks of confocal images (1 mm thick)
using an Olympus FV1000 scanning laser confocal microscope equipped with
a krypton/argon mixed gas laser. All of the analysis was performed with
ImageJ (NIH).
Drug Infusion of Unilateral SON
Rats were instrumented with unilateral cannula targeted at the SON as previ-
ously described (Carren˜o et al., 2011). Under isoflurane anesthesia (2%), the
rats were placed in a stereotaxic frame (Kopf Instruments), and a 28 gauge
cannula (Plastics One) was placed in the right SON. Each cannula was con-
nected to an osmotic pump implanted subcutaneously around the neck region
of rats (ALZET) filled with either saline or TrkB-Fc. After 7–10 days of recovery,
rats underwent a 7 day SL protocol and then were prepared into hypothalamic
explant preparations for in vitro electrophysiological experiments. The effi-
ciency of TrkB-Fc infusion was tested by post-hoc immunohistochemistry.
AAV-Mediated Knockdown of BDNF in the Supraoptic Nucleus
Adeno-associated virus (AAV) serotype 2 conjugated with shRNA directed
against BDNF was custom-generated (Vector Biolabs). To test the effective-
ness of the shRNA’s ability to induce a specific knockdown of BDNF in vitro,
HEK293T cells were transfected with 2 mg BDNF with or without BDNF-
shRNA. Twenty-four hours later, the conditioned media was collected and
concentrated and then run in a western blot. AAV conjugated with either the
BDNF- or scrambled (scr)-shRNA (Vector Biolabs) were injected intracerebro-
ventricularly (i.c.v.) into the third ventricle (2ml) to test the in vivo effectiveness of
knockdown in hypothalamic tissue. After 4weeks the rat brainswere harvested
and the anterior hypothalami were microdissected and processed for western
blotting. To induce a specific knockdown of BDNF in the supraoptic nucleus,
rats were stereotaxically injected with AAVs conjugated with either BDNF- or
scr-shRNA (1 ml; from Bregma, X: 1.5 mm, Y: 0.5 mm, Z: 7.7 mm). The virus
was allowed to express in vivo for 5–6 weeks, after which the rats underwent
a 7 day SL treatment. Their brains were harvested and prepared for hypotha-
lamic slices as described above. After patch-clamp recordings, the slices
were immersion-fixed in 4% paraformaldehyde overnight and processed for
post-hoc immunohistochemistry to confirm the success of knockdown.
Inhibition of Microglial Activation via Intraperitoneal Injections of
Minocycline
Minocycine hydrochloride (Sigma) was dissolved in 0.9% saline, and appro-
priate amounts of NaOH were added to adjust the pH to 7.4. Each rat
received a daily dose of 50mg/kg i.p. for 7 days, during which they also under-
went SL treatment. A control group of rats received injections of equal
amounts of saline. On the last day of SL, the rat brains were harvested and
made into hypothalamic slice preparations, and patch-clamp recordings
were performed.
Radio Telemetry Measurement of BP and In Vivo Infusion of VP
Antagonist
As previously described (Cunningham et al., 2012), rats were implanted with an
abdominal aortic catheter attached to a TA11PA-C40 radio telemetry trans-
mitter under isoflurane anesthesia (2%). The transmitter was secured to the
abdominal muscle and remained in the abdominal cavity for the duration of
the experiment. After a 2 week recovery period, MAP signals from the telem-
etry device were recorded during a 7 day SL protocol using a Dataquest IV ra-
dio telemetry system (Data Sciences Inc.). Prior to SL treatment, a subgroup of
these rats was also implanted with an osmotic minipump (ALZET) in a subcu-
taneous pouch made between the scapulae under isoflurane anesthesia (2%)
for subcutaneous drug infusion.
Statistics
All values in this study are reported as mean ± the standard error of the mean
(SEM). Unless explicitly stated, statistical differences between mean values
were tested using Student’s two-tailed t test. All statistical tests were per-
formed with Sigmaplot 12.3 (SPSS Inc.) or Prism 5 (Graphpad Software
Inc.). Data points above or below twice the standard deviation from the
mean were excluded from statistical comparisons. Differences between
values were considered to be significant when p < 0.05.
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